This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
557745 |
1. Apply sex-specific ruleNone |
557745 |
2. Check conditionsNone |
557745 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
566 |
4. Check minimum number of eventsNone |
566 |
5. Include endpointsNone |
566 |
6. Filter based on genotype QC (FinnGen only) |
506 |
Control definitions (FinnGen only)
- Control exclude
- F5_BEHEMOCHILD
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- F90-F98
- Name in latin
- Perturbationes ticiformes
Similar endpoints
↥List of similar endpoints to
Tic disorders
based on the number of shared cases.
Similar with more cases:
- Behavioural and emotional disorders with onset usually occurring in childhood and adolescence
- Psychiatric diseases
- Any prescribed medicine buy
- Any event in hilmo or specialist outpatient
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 506 | 266 | 240 |
| Unadjusted period prevalence (%) | 0.10 | 0.09 | 0.11 |
| Median age at first event (years) | 15.34 | 18.16 | 12.21 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 545
- Matched controls
- 5450
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
F95.9
ICD-10 Finland
Tic disorder, unspecified
3676.3
233.8
209
*
F95.2
ICD-10 Finland
Combined vocal and multiple motor tic disorder [de la Tourette]
+∞
217.7
194
*
N05AX08
ATC
risperidone; systemic
12.8
141.6
160
172
F90.0
ICD-10 Finland
Disturbance of activity and attention
13.3
129.8
139
137
F95.0
ICD-10 Finland
Transient tic disorder
683.1
115.5
110
*
N06BA04
ATC
methylphenidate; oral
12.2
111.9
125
130
N05AX12
ATC
aripiprazole; systemic
11.3
107.0
126
141
F95.1
ICD-10 Finland
Chronic motor or vocal tic disorder
1175.0
102.7
97
*
N05AD01
ATC
haloperidol; systemic
26.7
93.5
66
28
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
5.5
72.0
186
473
331
Kela drug reimbursment
Atomoxetine, dexamphetamine, guanfacine and lisdexamphetamine
22.1
71.3
54
27
N03AE01
ATC
clonazepam; systemic
11.6
66.7
73
72
IBZ01
NOMESCO Finland
Profession-specific psychiatric evaluation
10.1
66.0
80
91
ICB01
NOMESCO Finland
Psychiatric treatment plan, standard
7.8
65.8
102
157
F84.5
ICD-10 Finland
Asperger syndrome
26.7
60.0
42
17
IGY01
NOMESCO Finland
Accelerated psychiatric treatment contact
8.5
55.3
77
104
IGY99
NOMESCO Finland
Other psychiatric treatment contact
7.6
50.6
77
115
ICZ03
NOMESCO Finland
Participation in compiling a psychiatric treatment plan
6.6
49.3
87
152
IEY05
NOMESCO Finland
Dedicated profession-specific psychiatric intervention, individual
6.0
48.9
97
190
ZY010
NOMESCO Finland
Hospital outpatient
5.6
47.8
104
222
IFA01
NOMESCO Finland
Psychiatric pharmacotherapy plan, not specified
10.3
47.0
55
59
N06BA12
ATC
lisdexamfetamine; oral
16.5
46.4
40
26
IGY02
NOMESCO Finland
Psychiatric monitoring contact
5.7
43.7
91
186
F42.2
ICD-10 Finland
Mixed obsessional thoughts and acts
13.4
42.2
41
33
N06AB06
ATC
sertraline; oral
4.2
42.2
136
397
IGP01
NOMESCO Finland
Psychiatric family contact
9.5
42.0
52
60
N05AH04
ATC
quetiapine; oral
3.7
41.6
175
615
IBA04
NOMESCO Finland
Extensive initial psychiatric evaluation
7.4
41.2
63
94
IBA01
NOMESCO Finland
Diagnostic and symptom-mapping evaluation
7.2
41.0
65
101
F42.9
ICD-10 Finland
Obsessive-compulsive disorder, unspecified
13.5
39.6
38
30
N06AB03
ATC
fluoxetine; oral
4.8
39.4
101
246
ICB06, ,
NOMESCO Finland
14.2
38.6
36
27
112
Kela drug reimbursment
Severe psychotic and other severe mental disorders
5.5
38.3
81
167
N05AH03
ATC
olanzapine; systemic
5.1
37.9
88
197
IBZ06
NOMESCO Finland
Evaluation concerning developmental neuropsychiatry
107.7
37.3
40
*
F95.8
ICD-10 Finland
Other tic disorders
+∞
35.8
34
*
IGV01
NOMESCO Finland
Psychiatric network contact
9.4
34.1
42
48
ZYC01
NOMESCO Finland
Remote contact by phone
5.0
32.7
77
174
N05BA04
ATC
oxazepam; oral
3.1
31.1
171
694
30620
ICD-8 Finland
Special symptoms not elsewhere classified, Tics
+∞
30.5
29
*
F93.89
ICD-10 Finland
Other childhood emotional disorders
62.2
30.5
35
6
ICB03
NOMESCO Finland
Psychiatric treatment plan, monitoring
8.4
29.8
40
51
Z2445
NOMESCO Finland
Psychologist
4.3
28.9
83
219
N03AX09
ATC
lamotrigine; oral
5.0
28.4
66
147
IEV99
NOMESCO Finland
Other psychiatric network intervention
10.9
28.2
31
30
F32.9
ICD-10 Finland
Depressive episode, unspecified
3.2
27.5
132
491
N06AX12
ATC
bupropion; oral
4.0
27.3
85
238
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
4.4
26.4
72
182
ICC04
NOMESCO Finland
Psychiatric treatment plan, permanent discontinuation
5.3
26.1
56
116
N06AX16
ATC
venlafaxine; oral
3.4
25.6
107
365
ZXE06
NOMESCO Finland
Procedure duration 50 to 59 minutes
4.1
25.6
77
210
N05BA01
ATC
diazepam; systemic, rectal
3.9
25.6
83
239
F41.9
ICD-10 Finland
Anxiety disorder, unspecified
2.9
24.8
149
627
ZXE05
NOMESCO Finland
Procedure duration 40 to 49 minutes
4.5
24.7
65
160
ZXE11
NOMESCO Finland
Procedure duration 60 to 89 minutes
3.5
23.7
91
293
F33.9
ICD-10 Finland
Recurrent depressive disorder, unspecified
5.1
23.4
52
111
F29
ICD-10 Finland
Unspecified nonorganic psychosis
4.6
22.7
57
135
F33.10
ICD-10 Finland
Recurrent depression, moderate episode without somatic syndrome
4.4
22.6
61
153
N03AG01
ATC
valproic acid; systemic, rectal
4.4
22.5
60
149
ICB02
NOMESCO Finland
Psychiatric treatment plan, extended/prolonged
7.4
22.3
33
47
N06BA09
ATC
atomoxetine; oral
36.8
22.3
28
8
F42.0
ICD-10 Finland
Predominantly obsessional thoughts or ruminations
8.8
21.2
27
32
F60.30
ICD-10 Finland
Emotionally unstable personality disorder, impulsive
8.1
20.6
28
36
ZXY51
NOMESCO Finland
2-person team, doctor-nurse
6.5
20.4
34
55
N06AB10
ATC
escitalopram; oral
2.5
20.1
161
773
ZXE15
NOMESCO Finland
Procedure duration 120 to 149 minutes
5.5
19.9
40
78
F32.10
ICD-10 Finland
Moderate depressive episode without somatic syndrome
3.1
19.6
93
339
Z03.2
ICD-10 Finland
Observation for suspected mental and behavioural disorders
5.9
19.4
36
65
ZXE03
NOMESCO Finland
Procedure duration 20 to 29 minutes
3.9
18.5
57
157
N06AX26
ATC
vortioxetine; oral
3.2
18.2
81
284
ZXE13
NOMESCO Finland
Procedure duration 90 to 119 minutes
3.7
18.1
61
179
Z3231
NOMESCO Finland
Registered nurse
2.3
18.1
192
1039
IEP99
NOMESCO Finland
Other psychiatric family intervention
7.9
18.0
25
33
T36
ICD-10 Finland
Poisoning by systemic antibiotics
4.6
17.9
44
102
C07AA05
ATC
propranolol; systemic
2.5
17.6
136
638
N06AB05
ATC
paroxetine; oral
4.8
17.1
40
89
F92.9
ICD-10 Finland
Mixed disorder of conduct and emotions, unspecified
+∞
16.8
16
*
R1100
NOMESCO Finland
General evaluation of the need for rehabilitation
5.2
16.6
35
71
N06AB04
ATC
citalopram; systemic
2.9
16.4
88
343
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
2.9
16.1
82
310
F98.8
ICD-10 Finland
Other specified behavioural and emotional disorders with onset usually occurring in childhood and adolescence
61.9
15.8
18
*
ZXE04
NOMESCO Finland
Procedure duration 30 to 39 minutes
3.5
15.8
57
175
F92.8
ICD-10 Finland
Other mixed disorders of conduct and emotions
+∞
15.7
15
*
SPAT1240
SPAT
Therapeutic discussion
2.6
15.4
105
462
Z2446
NOMESCO Finland
Social worker
2.9
15.4
82
318
N06AX11
ATC
mirtazapine; oral
2.2
14.9
167
913
F32.2
ICD-10 Finland
Severe depressive episode without psychotic symptoms
3.2
14.9
63
214
SPAT1243
SPAT
Psychiatric/psychological examination
3.8
14.7
47
133
N05AG02
ATC
pimozide; oral
+∞
14.6
14
*
F93.9
ICD-10 Finland
Childhood emotional disorder, unspecified
+∞
14.6
14
*
C02AC02
ATC
guanfacine; oral
154.0
14.5
15
*
F90.9
ICD-10 Finland
Hyperkinetic disorder, unspecified
13.0
14.5
25
20
IAA01
NOMESCO Finland
Assessment of need for psychiatric treatment
3.3
14.1
55
177
F83
ICD-10 Finland
Mixed specific developmental disorders
4.9
13.9
31
66
IEP03
NOMESCO Finland
Focused parental counselling
6.4
13.8
23
37
G24.5
ICD-10 Finland
Blepharospasm
77.1
13.6
15
*
P29
ICPC
Psychological sympt/compl other
2.5
13.4
97
437
F42.1
ICD-10 Finland
Predominantly compulsive acts [obsessional rituals]
10.1
13.4
26
27
SPAT1307
SPAT
Psychosocial counselling and guidance
2.5
13.0
90
397
Z03.3
ICD-10 Finland
Observation for suspected nervous system disorder
3.4
12.9
49
155
P74
ICPC
Anxiety disorder/anxiety state
3.0
12.9
62
226
F32.3
ICD-10 Finland
Severe depressive episode with psychotic symptoms
6.0
12.8
23
40
IBA03
NOMESCO Finland
Psychotherapy evaluation
6.0
12.8
23
40
N05BA12
ATC
alprazolam; oral
3.4
12.5
47
148
R42
ICD-10 Finland
Dizziness and giddiness
2.4
12.4
100
473
NA1BG
NOMESCO Finland
Cervical spine MRI examination with high intensity magnet
4.1
12.2
34
87
IAZ98
NOMESCO Finland
Other internal psychiatric consultation
18.6
12.1
18
10
P99
ICPC
Psychological disorders other
4.0
12.1
35
92
N03AX12
ATC
[U] gabapentin; oral
2.8
11.9
65
254
ZXE02
NOMESCO Finland
Procedure duration 10 to 19 minutes
3.4
11.9
44
137
F33.2
ICD-10 Finland
Recurrent depressive disorder, current episode severe without psychotic symptoms
3.6
11.9
40
117
X69
ICD-10 Finland
Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances
4.4
11.9
30
71
F80.1
ICD-10 Finland
Expressive language disorder
4.6
11.8
28
63
Z76.0
ICD-10 Finland
Issue of repeat prescription
2.0
11.7
164
961
F84.0
ICD-10 Finland
Childhood autism
30.8
11.7
15
5
N06AX21
ATC
duloxetine; oral
2.8
11.7
62
239
Z01.8
ICD-10 Finland
Other specified special examinations
2.2
11.5
122
644
F32.00
ICD-10 Finland
Mild depressive episode without somatic syndrome
3.5
11.5
40
120
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
2.1
11.4
127
684
F33.4
ICD-10 Finland
Recurrent depressive disorder, currently in remission
4.5
11.4
28
65
F50.9
ICD-10 Finland
Eating disorder, unspecified
5.3
11.4
23
45
IFA99
NOMESCO Finland
Other psychiatric pharmacotherapy service
8.3
11.2
24
30
F41.8
ICD-10 Finland
Other specified anxiety disorders
3.3
11.1
44
143
N03AF01
ATC
carbamazepine; oral, rectal
5.0
11.1
24
50
F60.31
ICD-10 Finland
Emotionally unstable personality disorder, borderline condition
8.5
10.9
23
28
F88
ICD-10 Finland
Other disorders of psychological development
15.9
10.9
17
11
IEP02
NOMESCO Finland
Child-centred family therapy
5.3
10.9
22
43
N06AA04
ATC
clomipramine; systemic
9.1
10.9
22
25
R4160
NOMESCO Finland
Other therapy enhancing rehabilitation
4.0
10.8
31
81
F84.8
ICD-10 Finland
Other pervasive developmental disorders
18.3
10.8
16
9
F89
ICD-10 Finland
Unspecified disorder of psychological development
18.3
10.8
16
9
G51.3
ICD-10 Finland
Clonic hemifacial spasm
61.2
10.7
12
*
R56.8
ICD-10 Finland
Other and unspecified convulsions
2.8
10.6
54
203
N03AX16
ATC
[U] pregabalin
2.4
10.6
79
359
H53.1
ICD-10 Finland
Subjective visual disturbances
3.2
10.6
43
142
F95
ICD-10 Finland
Tic disorders
112.1
10.5
11
*
N04AA02
ATC
biperiden; systemic
12.4
10.4
18
15
F41.2
ICD-10 Finland
Mixed anxiety and depressive disorder
2.1
10.2
107
560
F34.1
ICD-10 Finland
Dysthymia
3.8
10.1
31
85
ZXE01
NOMESCO Finland
Procedure duration 0 to 9 minutes
4.6
10.1
24
54
P81
ICPC
Hyperkinetic disorder
4.6
10.1
24
54
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
2.1
10.0
117
638
XA800
NOMESCO Finland
Neuropsychological investigation
2.9
10.0
47
169
L01
ICPC
Neck symptom/complaint
2.2
10.0
100
515
F84.9
ICD-10 Finland
Pervasive developmental disorder, unspecified
12.5
9.9
17
14
N05CF01
ATC
zopiclone; oral
2.1
9.7
102
534
D01
ICPC
Abdominal pain/cramps general
2.1
9.7
113
615
N05BE01
ATC
buspirone; oral
4.7
9.6
22
48
P76
ICPC
Depressive disorder
2.5
9.5
64
277
ZXE20
NOMESCO Finland
More than three and less than five hours
2.5
9.5
64
278
F98.9
ICD-10 Finland
Unspecified behavioural and emotional disorders with onset usually occurring in childhood and adolescence
30.6
9.4
12
*
F98.02
ICD-10 Finland
Non-organic nocturnal and diurnal enuresis
+∞
9.4
9
*
111
Kela drug reimbursment
Epilepsy and comparable convulsive disorders
3.1
9.4
40
136
N05CD07
ATC
temazepam; oral
3.6
9.2
30
86
F39
ICD-10 Finland
Unspecified mood [affective] disorder
4.1
9.1
25
63
N02BF02
ATC
pregabalin; oral
3.2
9.1
36
117
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
2.4
9.1
63
277
F99
ICD-10 Finland
Mental disorder, not otherwise specified
4.2
9.1
24
59
P10
ICPC
Stammering/stuttering/tic
37.3
9.0
11
*
R53
ICD-10 Finland
Malaise and fatigue
1.9
9.0
143
864
Z76.8
ICD-10 Finland
Persons encountering health services in other specified circumstances
3.2
9.0
35
113
F45.8
ICD-10 Finland
Other somatoform disorders
2.6
8.9
55
229
F33.00
ICD-10 Finland
Recurrent depression, mild episode without somatic syndrome
4.0
8.8
25
65
G24.9
ICD-10 Finland
Dystonia, unspecified
50.8
8.7
10
*
P03
ICPC
Feeling depressed
2.0
8.7
109
609
Z00.8
ICD-10 Finland
Other general examinations
2.3
8.6
66
303
SPAT1389
SPAT
Visit based on need for special support
2.4
8.6
59
258
F61.0
ICD-10 Finland
Mixed personality disorders
9.2
8.6
17
19
N06AX22
ATC
agomelatine; oral
4.3
8.5
22
53
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
2.1
8.5
92
486
F10.1
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Harmful use
3.0
8.5
38
133
F93.80
ICD-10 Finland
Generalized anxiety in the bardom age
+∞
8.4
8
*
N05AA02
ATC
levomepromazine; systemic
4.2
8.3
22
54
F31.8
ICD-10 Finland
Other bipolar affective disorders
4.2
8.3
22
54
P27
ICPC
Fear of mental disorder
3.9
8.3
24
63
M03BX01
ATC
baclofen; systemic
7.3
8.3
19
27
A28
ICPC
Limited function/disability NOS
2.5
8.2
55
238
R41.8
ICD-10 Finland
Other and unspecified symptoms and signs involving cognitive functions and awareness
3.1
8.2
34
114
R25.3
ICD-10 Finland
Fasciculation
17.5
8.1
12
7
WX404
NOMESCO Finland
Intravenous generell anesthesy
1.9
8.0
111
641
ZY000
NOMESCO Finland
Hospital inpatient
4.5
8.0
19
43
IAZ99
NOMESCO Finland
Other psychiatric consultation
13.3
7.9
13
10
N06AA09
ATC
amitriptyline; systemic
3.3
7.9
29
90
SPAT1058
SPAT
PEF monitoring instruction
2.8
7.9
41
156
N05AB03
ATC
perphenazine; systemic, rectal
4.2
7.9
21
52
R4110
NOMESCO Finland
Physiotherapy
1.8
7.9
135
833
M79.6
ICD-10 Finland
Pain in limb
1.7
7.8
205
1428
S29
ICPC
Skin symptom/complaint other
1.9
7.7
121
725
ZXY82
NOMESCO Finland
Nurse in multidisciplinary team
7.6
7.7
17
23
F31.9
ICD-10 Finland
Bipolar affective disorder, unspecified
3.8
7.7
23
62
A01
ICPC
Pain general/multiple sites
2.4
7.7
55
245
F41.1
ICD-10 Finland
Generalized anxiety disorder
2.3
7.7
60
278
T82
ICPC
Obesity
3.2
7.7
30
97
P01
ICPC
Feeling anxious/nervous/tense
1.8
7.6
153
988
ICA03
NOMESCO Finland
Psychiatric treatment plan, outsourced psychotherapy
25.4
7.6
10
*
SPAT1241
SPAT
Extensive assessment of psychosocial situation
4.3
7.5
19
45
A29
ICPC
General symptom/complaint other
2.1
7.5
73
370
F91.9
ICD-10 Finland
Conduct disorder, unspecified
81.2
7.4
8
*
F93.1
ICD-10 Finland
Phobic anxiety disorder of childhood
81.2
7.4
8
*
F90.1
ICD-10 Finland
Hyperkinetic conduct disorder
+∞
7.3
7
*
F94.9
ICD-10 Finland
Childhood disorder of social functioning, unspecified
+∞
7.3
7
*
F91.3
ICD-10 Finland
Oppositional defiant disorder
+∞
7.3
7
*
ZY020
NOMESCO Finland
Telephone, letter or other consultation without direct patient contact
2.8
7.2
36
134
SPAT1222
SPAT
Counselling/guidance promoting independent living
2.2
7.1
60
287
IEP01
NOMESCO Finland
Psychoeducation, family
12.2
7.1
12
10
IBB01
NOMESCO Finland
Psychiatric functioning capacity evaluation
8.9
7.1
14
16
R52.2
ICD-10 Finland
Other chronic pain
4.0
7.0
20
52
A04
ICPC
Weakness/tiredness general
1.8
7.0
112
674
N05AF03
ATC
chlorprothixene; systemic
4.5
7.0
17
39
IER01
NOMESCO Finland
Psychoeducation, group
6.0
7.0
18
31
O99.3
ICD-10 Finland
Mental disorders and diseases of the nervous system complicating pregnancy, childbirth and the puerperium
4.1
6.9
19
48
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.6
6.9
208
1490
IDY03
NOMESCO Finland
Systematic individual therapy, cognitive-behavioural
2.3
6.9
52
237
R25.8
ICD-10 Finland
Other and unspecified abnormal involuntary movements
14.0
6.9
11
8
N07BB01
ATC
disulfiram; oral
3.5
6.9
23
67
F43.1
ICD-10 Finland
Post-traumatic stress disorder
3.0
6.9
31
109
P79
ICPC
Phobia/compulsive disorder
5.8
6.8
18
32
R4170
NOMESCO Finland
Therapy forms involving educational rehabilitation
40.6
6.8
8
*
G47.3
ICD-10 Finland
Sleep apnoea
2.0
6.8
75
399
N39.4
ICD-10 Finland
Other specified urinary incontinence
3.4
6.8
24
73
J45.9
ICD-10 Finland
Asthma, unspecified
1.9
6.8
96
556
IER03
NOMESCO Finland
Psychiatric disorder-specific group intervention
16.9
6.8
10
6
S18
ICPC
Laceration/cut
1.6
6.7
207
1489
F40.1
ICD-10 Finland
Social phobias
2.6
6.7
37
146
ZXY80
NOMESCO Finland
Doctor in multidisciplinary team
8.0
6.6
14
18
Z71.8
ICD-10 Finland
Other specified counselling
1.6
6.6
212
1539
N05AF01
ATC
flupentixol; systemic
12.4
6.6
11
9
Z01.0
ICD-10 Finland
Examination of eyes and vision
1.8
6.6
103
616
IAB01
NOMESCO Finland
Psychiatric pharmacotherapy consultation
6.3
6.5
16
26
Z61.2
ICD-10 Finland
Altered pattern of family relationships in childhood
70.6
6.4
7
*
F98.01
ICD-10 Finland
Non-organic diurnal enuresis
70.6
6.4
7
*
N08
ICPC
Abnormal involuntary movements
70.6
6.4
7
*
RT420, ,
NOMESCO Finland
14.5
6.4
10
7
Z3226
NOMESCO Finland
Physiotherapist
1.8
6.4
100
598
F41.3
ICD-10 Finland
Other mixed anxiety disorders
3.5
6.3
21
61
SPAT1395
SPAT
Health check-up of persons outside student and working life
5.6
6.3
17
31
IER02
NOMESCO Finland
Dedicated profession-specific psychiatric intervention, group
6.1
6.3
16
27
N05BA06
ATC
lorazepam; systemic, sublingual
3.4
6.3
22
66
ZXY81
NOMESCO Finland
Psychologist in multidisciplinary team
9.4
6.3
12
13
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
2.4
6.3
43
188
Z01
ICPC
Poverty/financial problem
18.3
6.3
9
5
F98.2
ICD-10 Finland
Feeding disorder of infancy and childhood
+∞
6.3
6
*
R07.4
ICD-10 Finland
Chest pain, unspecified
1.8
6.2
102
617
H13
ICPC
Plugged feeling ear
1.9
6.2
80
448
D09
ICPC
Nausea
2.1
6.2
61
310
F42
ICD-10 Finland
Obsessive-compulsive disorder
7.8
6.2
13
17
L17
ICPC
Foot/toe symptom/complaint
1.6
6.1
163
1126
D06
ICPC
Abdominal pain localized other
2.1
6.1
60
305
SPAT1220
SPAT
Assessment of need for rehabilitation and/or rehabilitation plan
2.6
6.1
35
141
ZXY52
NOMESCO Finland
2-person team, doctor-psychologist
10.2
6.1
11
11
F40.8
ICD-10 Finland
Other phobic anxiety disorders
10.2
6.1
11
11
SPAT1365
SPAT
Health check-up performed during first study year due to special need in students of upper secondary schools or vocational schools
5.7
6.0
16
29
A02BC02
ATC
pantoprazole; systemic
1.6
6.0
237
1796
XKD00
NOMESCO Finland
Uroflowmetry
2.5
6.0
38
160
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
148
680
2.62
20.28
2.5
1.7
1.51
1.39
%
1.46
138
620
206
1116
2.36
19.63
2.7
3.2
2.37
2.37
mmol/l
0.12
190
1034
444
3411
2.63
17.57
4.8
4.0
14.49
14.59
pmol/l
0.38
412
3110
157
818
2.29
15.84
1.8
1.4
18.68
19.98
nmol/l
0.63
141
727
279
1835
2.07
15.32
8.3
8.4
1.22
1.22
mmol/l
0.38
249
1628
219
1318
2.11
15.28
2.0
1.7
98.98
99.37
pmol/l
0.05
122
689
438
3479
2.32
13.82
4.4
3.3
5.61
5.58
mmol/l
0.14
414
3221
273
1838
1.97
13.46
3.0
2.9
69.33
70.47
nmol/l
0.28
262
1736
491
4125
2.92
13.41
17.1
12.4
3.92
3.92
mmol/l
0.05
485
3997
476
3951
2.62
13.09
6.1
4.7
1.86
1.83
mu/l
0.29
456
3731
373
2815
2.03
13.01
7.9
6.9
87.84
84.95
u/l
0.46
358
2668
220
1391
1.98
12.88
3.7
3.4
27.23
30.83
u/l
1.85
209
1326
223
1430
1.95
12.42
5.1
6.4
38.19
37.85
g/l
0.40
209
1361
387
2990
2.02
12.22
4.7
4.1
8.72
8.05
mm/h
0.47
364
2808
106
519
2.29
12.08
1.6
1.6
419.31
14629265.30
pmol/l
0.50
91
458
249
1679
1.89
11.73
7.5
8.4
1.22
1.22
mmol/l
0.06
237
1580
157
906
2.03
11.72
3.1
2.2
166.05
326.20
u/l
1.21
148
869
64
251
2.76
11.65
2.3
1.6
0.17
0.24
mg/l
0.78
25
111
189
1177
1.93
11.25
3.8
4.0
8.75
8.80
mmol/l
0.04
168
1066
81
366
2.42
11.03
1.6
1.7
1135.84
1126.86
nmol/l
0.03
66
287
258
1784
1.85
11.02
7.0
6.3
11.19
12.14
umol/l
0.40
248
1672
176
1085
1.92
10.71
2.7
2.6
52.71
61.45
u/l
0.96
165
1016
165
1007
1.92
10.28
2.9
3.2
1.02
1.02
kg/l
0.02
99
617
108
596
2.01
8.89
6.8
6.7
0.85
0.82
mmol/l
0.98
102
574
342
2694
1.72
8.40
12.2
10.6
3.67
3.83
e9/l
0.80
296
2303
167
1085
1.78
8.24
2.9
2.7
2.56
2.57
mg/l
0.02
146
941
308
2379
1.68
7.95
3.6
3.3
75.96
72.13
ug/l
0.21
291
2265
424
3581
1.83
7.84
14.7
10.0
100.74
100.06
ml/min/173m2
0.24
376
3060
370
3012
1.71
7.72
4.5
3.3
30.73
33.31
u/l
0.66
354
2907
331
2649
1.64
7.07
4.6
4.0
6211.20
482.41
e6/l
—
5
34
28
93
3.12
6.87
1.6
1.6
—
—
—
0
0
220
1602
1.63
6.84
1.6
1.7
0.81
2.06
u/ml
2.17
53
387
154
1025
1.70
6.78
3.7
2.9
27.90
34.68
ng/l
0.19
81
510
165
1127
1.67
6.56
3.2
3.6
0.00
0.00
estimate
0.50
61
428
92
536
1.86
6.35
2.6
2.7
2.41
2.42
mmol/l
0.51
87
477
97
577
1.83
6.26
2.8
2.7
14.75
13.90
umol/l
0.48
91
542
499
4547
2.15
6.01
12.5
9.4
27.89
27.19
u/l
0.34
490
4431
291
2312
1.55
5.98
5.2
5.5
6.20
6.36
mmol/l
0.67
268
2116
39
169
2.41
5.82
1.2
2.3
1.58
4.38
iu/ml
—
5
32
389
3319
1.60
5.70
4.8
4.3
36.35
36.90
mmol/mol
0.56
373
3183
280
2224
1.53
5.64
3.9
3.5
0.05
0.00
estimate
0.49
60
430
16
43
3.80
5.40
1.0
1.0
—
—
—
0
0
275
2192
1.51
5.34
3.7
3.4
0.00
0.00
estimate
-0.00
63
457
80
473
1.81
5.25
4.3
4.5
8.03
6.57
umol/l
0.18
68
401
89
544
1.76
5.22
2.6
2.7
2.49
2.45
g/l
0.34
84
508
276
2211
1.50
5.18
3.7
3.5
0.00
3.64
estimate
0.50
62
446
162
1158
1.57
5.17
3.6
3.5
0.37
0.23
e6/l
0.41
121
831
423
3730
1.60
4.92
4.5
3.9
2.68
2.74
mmol/l
0.83
407
3548
419
3700
1.57
4.70
4.1
3.6
1.37
1.41
mmol/l
1.06
402
3526
28
116
2.49
4.63
1.4
1.2
—
—
—
0
0
127
879
1.58
4.60
2.4
3.0
9.46
6.36
e6/l
1.03
111
789
421
3730
1.57
4.57
4.2
3.7
4.43
4.56
mmol/l
2.03
406
3566
78
479
1.73
4.49
1.1
1.1
—
—
—
0
0
69
409
1.79
4.49
1.6
1.4
296.50
334.78
u/ml
0.15
62
382
393
3439
1.51
4.44
3.6
3.2
1.19
1.20
mmol/l
0.08
375
3263
68
403
1.79
4.42
2.3
2.4
165.19
31.63
u/l
0.52
59
334
45
233
2.02
4.40
2.0
1.8
—
—
—
0
0
23
92
2.57
4.10
1.5
1.4
226.40
311.77
ug/g
—
10
56
53
302
1.84
3.93
2.3
2.3
11.91
12.91
au/ml
—
7
32
12
28
4.36
3.83
1.3
2.6
10.44
17.28
umol/l
1.55
12
28
186
1446
1.43
3.75
1.7
1.6
1.84
1.96
g/l
0.60
114
854
119
848
1.52
3.73
3.5
2.8
0.98
1.15
mg/l
0.31
75
606
98
675
1.55
3.58
3.7
3.2
1.79
2.82
e6/l
1.13
56
317
533
5118
2.88
3.54
25.0
17.4
88.28
88.37
fl
0.16
527
5077
533
5119
2.87
3.52
25.6
17.9
40.79
42.41
%
0.82
527
5074
533
5119
2.87
3.52
25.1
17.4
4.66
4.65
e12/l
0.13
516
4979
45
253
1.85
3.49
1.6
1.7
—
—
—
0
0
89
603
1.57
3.49
3.6
4.0
408.65
1275.88
ng/l
2.15
71
473
533
5123
2.84
3.44
25.3
17.6
136.99
137.46
g/l
0.32
527
5081
66
418
1.66
3.41
1.2
1.3
144.36
138.33
u/ml
0.04
23
137
48
278
1.80
3.40
5.2
5.8
—
—
—
0
0
98
684
1.53
3.37
1.4
1.3
17.72
25.29
iu/ml
0.42
18
187
532
5114
2.69
3.33
25.2
17.5
260.68
259.05
e9/l
0.25
517
4988
33
170
2.00
3.31
2.1
2.2
6.07
8.68
ug/l
0.25
27
145
203
1631
1.39
3.31
3.2
3.1
0.10
0.01
estimate
0.72
50
390
46
266
1.80
3.28
1.7
1.5
—
—
—
0
0
59
373
1.65
3.08
6.9
9.1
1.52
1.40
mmol/l
0.24
59
364
8
16
5.06
3.06
1.0
1.2
—
—
—
0
0
8
16
5.06
3.06
1.0
1.2
—
—
—
0
0
81
560
1.52
2.91
2.0
1.8
—
—
—
0
0
484
4545
1.58
2.89
16.7
11.7
19.09
22.49
mg/l
2.06
374
3451
98
712
1.46
2.77
3.6
3.1
0.59
0.71
e6/l
0.36
56
351
7
14
5.05
2.73
1.0
1.1
—
—
—
0
0
7
14
5.05
2.73
1.0
1.1
—
—
—
0
0
7
15
4.71
2.60
1.0
1.3
—
—
—
0
0
20
94
2.17
2.58
1.3
1.2
—
16.87
—
0
6
22
108
2.08
2.55
1.3
1.3
—
3.49
—
0
8
86
620
1.46
2.53
3.4
3.0
232.51
858.95
ng/l
1.49
37
355
12
45
2.70
2.46
1.1
1.2
—
—
—
0
0
13
51
2.59
2.46
1.2
1.1
—
—
—
0
0
13
52
2.54
2.37
1.0
1.1
—
—
—
0
0
10
33
3.07
2.36
1.1
1.1
258.50
290.29
mg/l
—
10
28
80
577
1.45
2.35
5.8
7.6
1.71
1.38
mmol/l
0.57
68
479
18
85
2.16
2.31
1.4
1.4
—
—
—
0
0
60
412
1.51
2.25
2.0
1.7
—
—
—
0
0
116
902
1.36
2.22
3.3
3.2
149.82
114.54
ug/g
0.55
93
729
15
67
2.27
2.19
2.2
4.2
212.00
199.73
e6/l
—
9
48
14
61
2.33
2.16
5.9
3.5
97.14
97.84
%
0.03
14
61
50
336
1.54
2.08
3.5
3.3
31.35
31.30
%
0.01
37
243
58
404
1.49
2.04
2.0
1.8
—
—
—
0
0
(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay
10
38
2.66
2.01
1.3
1.7
160.78
130.18
%
—
10
38
177
1483
1.29
1.99
2.1
1.8
1.37
1.35
mmol/l
0.10
148
1331
31
187
1.70
1.98
1.8
1.6
—
—
—
0
0
14
64
2.22
1.96
2.0
4.4
13.07
9.16
%
0.86
14
64
5
11
4.58
1.94
1.2
1.0
8.60
16.27
u/l
—
5
11
5
11
4.58
1.94
1.0
1.2
—
—
—
0
0
445
4189
1.34
1.89
21.1
14.9
13.17
13.14
%
0.17
440
4139
5
12
4.19
1.82
1.0
1.2
—
—
—
0
0
8
29
2.78
1.79
1.0
1.3
—
—
—
0
0
34
217
1.60
1.78
3.9
5.0
1.22
1.23
mmol/l
0.70
27
192
14
67
2.12
1.77
2.1
4.1
470.00
505.62
e6/l
—
8
45
83
637
1.36
1.73
1.5
1.3
8.34
7.38
u/ml
0.06
34
256
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
14
69
2.06
1.66
4.4
9.8
0.28
0.37
iu/ml
—
9
38
11
49
2.27
1.64
1.2
1.1
—
—
—
0
0
46
324
1.46
1.57
1.4
1.3
187.88
257.30
miu/ml
0.72
16
161
13
245
0.52
1.56
1.7
1.8
—
—
—
0
0
8
33
2.44
1.54
1.0
1.1
—
—
—
0
0
60
447
1.38
1.52
5.7
6.5
1.05
0.95
mmol/l
0.12
40
335
34
227
1.53
1.50
1.3
1.6
321.20
182.69
u/ml
1.11
15
129
21
124
1.72
1.49
1.7
2.0
—
—
—
0
0
59
443
1.37
1.43
7.9
8.5
105.68
104.58
mmol/l
1.09
59
443
38
534
0.69
1.41
1.4
1.5
3.45
3.34
mmol/l
0.31
25
347
61
462
1.36
1.41
3.9
2.5
2812.90
6797.51
u/l
1.05
22
181
11
53
2.10
1.39
1.3
1.4
—
—
—
0
0
50
668
0.72
1.39
1.5
1.7
3.53
3.43
ratio
0.24
37
475
149
1273
1.23
1.37
3.2
2.8
0.02
0.00
estimate
0.40
51
376
44
318
1.42
1.34
1.2
1.3
2.55
2.65
u/ml
0.03
32
213
41
293
1.43
1.33
1.1
1.2
4.82
6.08
u/ml
0.33
30
209
90
729
1.28
1.31
4.4
4.7
11.27
11.36
mg/mmol
0.00
60
509
9
43
2.11
1.31
1.2
1.3
—
—
—
0
0
9
43
2.11
1.31
1.2
1.3
—
—
—
0
0
15
255
0.58
1.30
1.7
1.7
—
—
—
0
0
165
1434
1.22
1.28
3.3
2.5
—
—
—
0
0
12
62
1.96
1.28
2.1
4.5
—
—
—
0
0
11
55
2.02
1.28
2.2
4.7
31.55
27.38
%
0.52
11
55
9
44
2.06
1.27
1.3
1.3
—
—
—
0
0
9
44
2.06
1.27
1.2
1.3
—
—
—
0
0
17
100
1.72
1.25
1.5
1.6
—
—
—
0
0
9
45
2.02
1.24
1.3
1.3
—
—
—
0
0
9
45
2.02
1.24
1.3
1.3
—
—
—
0
0
19
116
1.66
1.23
1.6
2.0
—
—
—
0
0
26
172
1.54
1.23
1.6
1.7
4.90
5.69
u/ml
—
5
43
29
197
1.50
1.22
1.4
1.8
2.87
2.98
mg/l
0.05
24
130
39
282
1.41
1.20
3.7
2.8
—
—
—
0
0
8
38
2.12
1.19
3.6
4.6
0.75
0.76
index
—
8
38
21
134
1.59
1.16
2.1
2.3
2.79
5.06
iu/l
—
9
57
5
20
2.51
1.15
1.8
5.5
136.00
156.00
ug/l
—
5
20
26
176
1.50
1.12
1.3
1.4
—
—
—
0
0
116
986
1.22
1.12
2.9
2.6
—
—
—
0
0
36
261
1.41
1.11
11.2
15.4
1.12
1.05
mg/l
0.37
36
251
5
21
2.39
1.09
2.2
2.6
—
—
—
0
0
7
32
2.20
1.08
2.4
3.6
692.29
654.59
u/ml
—
7
32
11
59
1.88
1.08
1.2
1.3
—
—
—
0
0
28
195
1.46
1.06
4.3
6.1
0.61
0.62
%
0.06
28
195
5
22
2.28
1.03
1.0
1.0
—
—
—
0
0
7
34
2.07
1.03
1.3
1.2
112.43
108.74
pmol/l
—
7
34
26
181
1.46
1.00
5.0
3.0
86.94
154.38
ng/l
1.16
18
159
7
133
0.52
1.00
1.4
1.8
—
—
—
0
0
107
914
1.21
0.99
3.0
2.4
—
—
—
0
0
0
30
0.00
0.97
0.0
1.1
—
—
—
0
0
9
50
1.81
0.97
1.1
1.3
—
—
—
0
0
15
94
1.61
0.91
1.1
1.3
—
—
—
0
0
37
280
1.34
0.91
1.1
1.2
2.73
2.57
u/ml
0.04
28
190
38
289
1.34
0.91
1.1
1.2
1.21
0.95
u/ml
0.15
25
175
(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay
6
29
2.08
0.89
1.0
1.2
100.33
105.72
%
—
6
29
20
136
1.49
0.87
1.0
1.1
—
—
—
0
0
14
88
1.61
0.85
1.2
1.3
—
1.55
—
0
6
6
31
1.95
0.84
1.0
1.1
—
—
—
0
0
6
31
1.95
0.84
1.3
1.2
338.00
158.77
iu/ml
—
6
31
13
81
1.62
0.82
1.8
2.0
—
—
—
0
0
8
47
1.71
0.81
1.0
1.3
—
—
—
0
0
10
58
1.74
0.80
2.2
6.0
5.55
6.55
pmol/l
—
10
58
8
48
1.68
0.79
1.1
1.2
—
—
—
0
0
8
48
1.68
0.79
1.3
1.3
—
—
—
0
0
20
140
1.44
0.78
1.0
1.2
—
—
—
0
0
22
158
1.41
0.75
10.7
12.6
16.93
16.21
%
0.81
22
148
15
217
0.68
0.71
1.4
1.6
71.56
54.90
ug/l
0.88
15
217
16
109
1.48
0.71
1.6
1.4
—
—
—
0
0
16
109
1.48
0.71
1.6
1.4
—
—
—
0
0
167
1524
1.14
0.69
3.4
2.6
—
—
—
0
0
30
232
1.31
0.67
1.5
1.4
—
—
—
0
0
17
119
1.44
0.67
4.2
3.1
2.10
4.81
index
—
10
71
23
172
1.35
0.64
3.7
4.5
6.92
6.15
ug/l
0.06
17
133
12
79
1.53
0.63
1.8
1.7
0.51
0.52
e9/l
0.09
12
79
90
792
1.16
0.62
2.7
2.3
—
—
—
0
0
8
49
1.64
0.62
1.1
1.2
—
—
—
0
0
8
49
1.64
0.62
1.1
1.2
—
—
—
0
0
41
336
1.24
0.60
1.9
2.1
12.09
13.10
iu/l
0.11
27
237
19
140
1.37
0.59
1.2
1.1
—
—
—
0
0
16
115
1.40
0.57
1.4
1.5
—
—
—
0
0
19
141
1.36
0.57
1.4
1.2
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
6
37
1.63
0.55
1.0
1.1
—
—
—
0
0
6
38
1.59
0.54
1.5
1.5
82.00
83.82
%
—
6
38
6
38
1.59
0.54
1.8
1.8
—
—
—
0
0
9
61
1.48
0.54
2.0
1.5
—
—
—
0
0
10
66
1.52
0.53
1.9
2.0
—
—
—
0
0
21
161
1.32
0.52
1.9
1.7
93.45
111.46
au/ml
0.49
11
57
13
92
1.42
0.51
2.1
3.1
—
—
—
0
0
17
127
1.35
0.50
1.1
1.5
0.43
0.36
nmol/l
0.20
12
104
7
45
1.56
0.49
1.6
1.2
—
—
—
0
0
55
477
1.17
0.48
2.3
2.4
13.76
12.72
nmol/l
0.26
46
452
7
47
1.50
0.47
1.0
1.2
21.51
18.90
u/l
—
7
40
64
563
1.15
0.47
3.8
3.5
1.58
1.39
ug/l
0.20
57
507
13
94
1.39
0.46
2.1
1.5
—
—
—
0
0
5
83
0.60
0.46
2.6
1.5
—
—
—
0
0
29
350
0.82
0.44
1.4
1.5
—
—
—
0
0
5
31
1.62
0.43
1.0
1.1
—
—
—
0
0
191
1802
1.09
0.43
3.3
2.9
—
—
estimate
—
0
0
8
56
1.43
0.42
1.1
1.2
—
—
—
0
0
5
32
1.57
0.42
3.2
5.8
—
—
—
0
0
5
32
1.57
0.42
1.0
1.1
—
—
—
0
0
5
32
1.57
0.42
3.2
5.8
—
—
—
0
0
8
58
1.38
0.41
1.4
1.6
—
—
—
0
0
0
16
0.00
0.41
0.0
2.8
—
29.63
—
0
16
31
261
1.20
0.39
1.5
1.4
—
—
—
0
0
44
383
1.16
0.38
1.3
1.3
—
—
—
0
0
5
36
1.39
0.38
1.0
1.1
2694.20
1269.25
miu/ml
—
5
36
5
36
1.39
0.38
1.4
1.3
—
—
—
0
0
9
70
1.29
0.37
1.8
2.0
—
—
—
0
0
198
1886
1.08
0.35
2.3
1.9
—
—
—
0
0
6
46
1.31
0.33
1.5
1.7
—
—
—
0
0
34
296
1.16
0.31
9.6
10.7
0.60
0.62
mmol/l
0.01
26
247
427
4199
1.08
0.28
4.2
3.9
—
—
—
0
0
22
187
1.18
0.27
13.0
11.2
24.37
24.33
mmol/l
0.03
22
182
11
86
1.28
0.26
1.8
1.8
8.17
4.55
ug/l
0.23
11
76
23
197
1.17
0.26
1.0
1.1
7.39
9.26
u/ml
0.12
14
118
25
216
1.16
0.26
1.0
1.1
7.20
6.64
u/ml
0.05
16
137
22
256
0.85
0.26
1.6
1.5
—
—
—
0
0
75
696
1.09
0.26
1.5
1.5
—
—
—
0
0
13
105
1.24
0.25
2.1
1.9
—
2506.67
—
0
6
11
88
1.26
0.22
1.3
1.1
—
—
—
0
0
0
10
0.00
0.21
0.0
1.4
—
7.30
—
0
10
0
12
0.00
0.21
0.0
1.4
—
26.16
—
0
12
79
743
1.07
0.21
4.9
3.4
318.53
327.01
umol/l
0.31
74
686
0
13
0.00
0.21
0.0
3.7
—
6.02
—
0
13
0
14
0.00
0.20
0.0
1.4
—
—
—
0
0
28
251
1.12
0.19
10.6
11.5
121.61
123.48
g/l
0.22
28
243
6
53
1.13
0.18
5.0
5.5
2.11
1.61
ug/l
—
6
53
13
109
1.20
0.18
2.5
3.0
16.38
20.01
mu/l
0.26
13
102
13
109
1.20
0.18
1.8
1.6
—
—
—
0
0
32
352
0.90
0.18
3.3
2.3
0.65
0.68
ug/l
0.07
18
162
7
59
1.19
0.18
2.7
1.4
—
—
—
0
0
25
225
1.12
0.16
1.7
2.9
86.60
80.02
ml/min/173m2
—
10
84
6
80
0.75
0.15
1.8
1.4
—
69.71
—
0
7
15
169
0.88
0.13
1.2
1.3
—
—
—
0
0
28
261
1.08
0.10
1.3
1.3
—
—
—
0
0
7
80
0.87
0.07
1.0
1.4
14.77
16.54
u/l
—
7
72
7
80
0.87
0.07
2.6
2.1
—
—
—
0
0
9
88
1.02
0.07
1.9
1.8
—
—
—
0
0
14
152
0.92
0.06
1.6
2.1
220.21
221.49
pmol/l
0.01
14
147
14
130
1.08
0.04
4.1
10.3
24.09
24.50
mmol/l
0.20
14
119
12
129
0.93
0.03
1.7
1.8
—
—
—
0
0
12
126
0.95
0.00
1.7
1.7
—
—
—
0
0
20
194
1.03
0.00
1.5
1.6
0.11
0.12
iu/ml
—
6
37
33
324
1.02
0.00
1.9
2.2
5.60
6.03
u/l
0.18
23
222
20
195
1.03
0.00
1.0
1.1
0.20
0.66
u/ml
—
10
90
15
154
0.97
0.00
1.3
1.3
—
—
—
0
0
12
117
1.03
0.00
1.8
1.4
—
—
—
0
0
43
433
0.99
0.00
3.2
3.2
21.29
22.71
%
0.23
11
140
13
131
0.99
0.00
5.4
4.9
24.46
24.50
mmol/l
0.02
13
122
26
261
1.00
0.00
2.0
1.8
—
—
—
0
0
0
9
0.00
0.00
0.0
1.3
—
—
—
0
0
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
0
9
0.00
0.00
0.0
1.3
—
—
—
0
0
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
8
0.00
-0.00
0.0
11.4
—
—
—
0
0
0
5
0.00
-0.00
0.0
3.6
—
—
—
0
0
6
61
0.98
-0.00
1.7
1.6
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.1
—
1.25
—
0
8
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: F5_TIC – Tic disorders
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).